Literature DB >> 22568870

Expression of selected genes in preterm premature rupture of fetal membranes.

Paweł Kuć1, Piotr Laudański, Oksana Kowalczuk, Lech Chyczewski, Tadeusz Laudański.   

Abstract

OBJECTIVE: To analyse the expression of 15 genes encoding receptors and enzymes associated with the molecular mechanism of the tocolytic drugs atosiban (oxytocin receptor antagonist), nifedipine (calcium channel blocker) and celecoxib (selective cyclo-oxygenase-2 inhibitor) in preterm labor patients with premature rupture of fetal membranes in relation to symptoms of intrauterine infection and preterm labor risk factors.
DESIGN: Experimental molecular study.
SETTING: Tertiary obstetric care center. SAMPLE: Myometrial samples were obtained during cesarean sections from 35 patients who delivered preterm with unverified symptoms of intrauterine infection, 35 patients who delivered preterm without symptoms of intrauterine infection and 90 women who delivered at term.
METHODS: The Micro Fluidic Profiling Card analytic system was used to evaluate mRNA expression of the genes of interest. MAIN OUTCOME MEASURES: The relative quantification values for mRNA expression.
RESULTS: The median oxytocin receptor and cyclo-oxygenase-2 mRNA expression in preterm patients with clinical symptoms of intrauterine infection was significantly higher than in preterm patients without symptoms. The median mRNA expression of β(1) , β(3) and β(4) subunits of the L-type calcium channel and prostaglandin E(2) receptor was significantly higher in preterm patients compared with term patients.
CONCLUSIONS: The mRNA expression of hormones, enzymes and their receptors associated with tocolytic actions can differ in various clinical conditions. The expression of these genes is regulated at different levels and can be modified by inflammatory factors, which affect their functions.
© 2012 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2012 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22568870     DOI: 10.1111/j.1600-0412.2012.01445.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  5 in total

1.  Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome.

Authors:  Piotr Laudanski; Monika Zbucka-Kretowska; Karol Charkiewicz; Slawomir Wolczynski; Daniela Wojcik; Radoslaw Charkiewicz
Journal:  Mediators Inflamm       Date:  2014-11-16       Impact factor: 4.711

2.  Maternal Plasma Metabolomic Profiles in Spontaneous Preterm Birth: Preliminary Results.

Authors:  Barbara Lizewska; Joanna Teul; Pawel Kuc; Adam Lemancewicz; Karol Charkiewicz; Joanna Goscik; Marian Kacerovsky; Ramkumar Menon; Wojciech Miltyk; Piotr Laudanski
Journal:  Mediators Inflamm       Date:  2018-02-15       Impact factor: 4.711

Review 3.  Metabolomics in Prenatal Medicine: A Review.

Authors:  Giovanni Monni; Luigi Atzori; Valentina Corda; Francesca Dessolis; Ambra Iuculano; K Joseph Hurt; Federica Murgia
Journal:  Front Med (Lausanne)       Date:  2021-06-25

4.  Chemokines profiling of patients with preterm birth.

Authors:  Piotr Laudanski; Adam Lemancewicz; Pawel Kuc; Karol Charkiewicz; Barbara Ramotowska; Malgorzata Kretowska; Elwira Jasinska; Grzegorz Raba; Katarzyna Karwasik-Kajszczarek; Janusz Kraczkowski; Tadeusz Laudanski
Journal:  Mediators Inflamm       Date:  2014-04-28       Impact factor: 4.711

5.  Identification of Indicators for Preterm Birth Using Retinoid Metabolites.

Authors:  Young-Ah You; Soo-Yeon Hwang; Soo-Min Kim; Seojeong Park; Ga-In Lee; Sunwha Park; AbuZar Ansari; Jeongae Lee; Youngjoo Kwon; Young-Ju Kim
Journal:  Metabolites       Date:  2021-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.